Table of Contents
Clinical Takeaway
A randomized controlled trial tested the Minder mobile app, co-developed with university students, to address mental health and substance use challenges during the high-risk college transition period. The study evaluated whether this scalable digital tool could produce measurable improvements in mental health and substance use outcomes across a general university population. Results from this trial offer direct evidence on whether app-based interventions can serve as a practical, accessible support option for students who may not seek traditional clinical care.
#8 Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.
Citation: Vereschagin Melissa et al.. Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.. Journal of medical Internet research. 2024. PMID: 38536225.
Design: 5 Journal: 0 N: 3 Recency: 1 Pop: 2 Human: 1 Risk: 0
Abstract: BACKGROUND: University attendance represents a transition period for students that often coincides with the emergence of mental health and substance use challenges. Digital interventions have been identified as a promising means of supporting students due to their scalability, adaptability, and acceptability. Minder is a mental health and substance use mobile app that was codeveloped with university students. OBJECTIVE: This study aims to examine the effectiveness of the Minder mobile app in improving mental health and substance use outcomes in a general population of university students. METHODS: A 2-arm, parallel-assignment, single-blinded, 30-day randomized controlled trial was used to evaluate Minder using intention-to-treat analysis. In total, 1489 participants were recruited and randomly assigned to the intervention (n=743, 49.9%) or waitlist control (n=746, 50.1%) condition. The Minder app delivers evidence-based content through an automated chatbot and connects participants with services and university social groups. Participants are also assigned a trained peer coach to support them. The primary outcomes were measured through in-app self-assessments and included changes in general anxiety symptomology, depressive symptomology, and alcohol consumption risk measured using the 7-item General Anxiety Disorder scale, 9-item Patient Health Questionnaire, and US Alcohol Use Disorders Identification Test-Consumption Scale, respectively, from baseline to 30-day follow-up. Secondary outcomes included measures related to changes in the frequency of substance use (cannabis, alcohol, opioids, and nonmedical stimulants) and mental well-being. Generalized linear mixed-effects models were used to examine each outcome. RESULTS: In total, 79.3% (589/743) of participants in the intervention group and 83% (619/746) of participants in the control group completed the follow-up survey. The intervention group had significantly greater average reductions in anxiety symptoms measure
What This Study Teaches Us
A mobile app combining automated mental health content, peer coaching, and service linkage showed modest improvements in anxiety and depression symptoms among university students over 30 days, with about 79% retention. The intervention did not significantly reduce alcohol or substance use in this general student population.
Why This Matters Clinically
University mental health screening and early intervention remain clinically important, and digital tools offer scalability where in-person capacity is limited. However, clinicians should know that app-based interventions alone may not move the needle on substance use behaviors, which often require more intensive or multimodal approaches.
Study Snapshot
| Study Design | 2-arm parallel-assignment single-blinded randomized controlled trial, 30-day duration, intention-to-treat analysis |
| Population | 1489 university students (N=743 intervention, N=746 control); general student population without restriction to high-risk or diagnosed groups; demographics not specified in abstract |
| Intervention | Minder mobile app providing automated evidence-based chatbot content, connections to campus services and social groups, and assignment of a trained peer coach for 30 days |
| Primary Outcome | Change in anxiety (GAD-7), depression (PHQ-9), and alcohol use risk (AUDIT-C) from baseline to 30 days measured via in-app self-assessments |
| Key Result | 79.3% retention in intervention arm; abstract does not provide specific effect sizes or p-values for primary outcomes, only states partial results |
Where This Paper Deserves Skepticism
The abstract is incomplete, cutting off mid-results without reporting actual effect sizes, confidence intervals, or statistical significance for the primary outcomes. A 30-day timeframe is very short for evaluating substance use change, and the study measures only frequency, not clinical consequences or disorder status. The reliance on in-app self-report without objective biomarkers or blinded assessment introduces bias. The paper does not specify baseline demographic characteristics or whether groups were balanced, raising questions about selection bias in a university sample that may skew toward higher-functioning students willing to use an app.
Dr. Caplan’s Take
Digital mental health tools for students have intuitive appeal and this study shows decent engagement, but I want to see the full results before drawing conclusions about clinical benefit. The 30-day window is frankly too short to tell us whether anxiety or depression actually improve in a clinically meaningful way, and the lack of reported effect sizes in the abstract is concerning. For substance use in particular, an app without behavioral coaching or community reinforcement is unlikely to shift entrenched patterns in university students. If this tool is offered, it should be part of a broader support ecosystem, not a replacement for access to counseling or brief interventions when indicated.
Clinical Bottom Line
A mobile app with peer support and chatbot content showed acceptable uptake in university students, but the abstract does not provide sufficient data to determine whether it meaningfully improves anxiety, depression, or substance use outcomes. Clinicians should view it as a potential screening or engagement tool, not as a substitute for evidence-based counseling or behavioral intervention.
| |
Have thoughts on this? Share it: